Cambridge Cognition Holdings PLC
LSE:COG

Watchlist Manager
Cambridge Cognition Holdings PLC Logo
Cambridge Cognition Holdings PLC
LSE:COG
Watchlist
Price: 28 GBX 1.82% Market Closed
Market Cap: 11.7m GBX
Have any thoughts about
Cambridge Cognition Holdings PLC?
Write Note

Cambridge Cognition Holdings PLC
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cambridge Cognition Holdings PLC
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Cambridge Cognition Holdings PLC
LSE:COG
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Renalytix PLC
LSE:RENX
PP&E Gross
$1.2m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Craneware PLC
LSE:CRW
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intelligent Ultrasound Group PLC
LSE:IUG
PP&E Gross
ÂŁ1.3m
CAGR 3-Years
-1%
CAGR 5-Years
25%
CAGR 10-Years
N/A
EMIS Group PLC
LSE:EMIS
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Doctor Care Anywhere Group PLC
ASX:DOC
PP&E Gross
ÂŁ747k
CAGR 3-Years
-24%
CAGR 5-Years
39%
CAGR 10-Years
N/A
No Stocks Found

Cambridge Cognition Holdings PLC
Glance View

Market Cap
11.7m GBX
Industry
Health Care

Cambridge Cognition Holdings Plc is a neuroscience digital health company, which engages in the development of digital health products to better understand, detect, and treat conditions affecting brain health. The firm develops and markets digital solutions to assess brain health for sale worldwide, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight and NeuroVocalix. Its services include neuroscience consultancy, study design, data analysis, study management, data management plan, reporting and interpretation and technical consultancy. Its CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas. Its Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone applications for high frequency data collection to demonstrate treatment efficacy and increase the understanding of a disease and a patient's response to medication.

COG Intrinsic Value
104.23 GBX
Undervaluation 73%
Intrinsic Value
Price

See Also

Back to Top